Searchable abstracts of presentations at key conferences in endocrinology

ea0077p232 | Neuroendocrinology and Pituitary | SFEBES2021

Dramatic resolution of a pituitary macroadenoma: non-functioning or prolactin-secreting?

Mohamed Mousa Abdusalam , Ashraf Tanveer , Lessan Nader

Background: Non-functioning pituitary tumours can be associated with a modestly elevated prolactin. Response to dopamine agonist therapy in such cases is unusual. Large macroprolactinomas are associated with much higher prolactin levels and respond well to dopamine agonists.Case: We report a 41-year-old man with a pituitary macroadenoma associated with an elevated prolactin of around 2000mIU/l who developed marked resolution in his pituitary MRI images r...

ea0086p168 | Adrenal and Cardiovascular | SFEBES2022

Inclisiran for the treatment of hypercholesterolemia in clinical settings

Iqbal Sajid , Sabbour Hani , Ashraf Tanveer , Buckley Adam

Background: Inclisiran is the first clinically available small interfering RNA (siRNA)-based treatment, has been shown to reduce pro-atherogenic lipoproteins in patients with or without familial hypercholesterolemia (FH), diabetes mellitus (DM), or atherosclerotic cardiovascular disease (ASCVD), but has not been evaluated in Middle Eastern populations.Methods: Retrospective review of patients initiating inclisiran treatment for any indication at our cent...

ea0073aep161 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

An analysis of flash glucose monitoring (FGM) data on insulin-treated patients with diabetes: Effects of COVID-19 lockdown

Ashraf Tanveer , Helal Radwa , Majeed Maria , Lessan Nader

IntroductionFollowing the WHO declaration of COVID-19 as a pandemic and as many countries around the world, the United Arab Emirates government introduced gradual measures to stop the spread of the virus placing the country in a state of almost complete-lockdown. We report the impact of these restrictions on glucose control in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) on insulin therapy.Methods<p class="abst...

ea0099p427 | Adrenal and Cardiovascular Endocrinology | ECE2024

First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population

Ashraf Tanveer , Iqbal Sajid , Sabbour Hani , Lessan Nader , Buckley Adam

Purpose: Inclisiran is the first small interfering RNA (siRNA)-based treatment approved to reduce pro-atherogenic lipoproteins in patients with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein cholesterol (LDL-C). We report, to the best of our knowledge, the first evaluation of its effects in a Middle Eastern population.Methods: Retrosp...

ea0065p178 | Metabolism and Obesity | SFEBES2019

Glycaemic response to a mixed meal challenge: does camel milk preload confer an advantage?

Moriarty Maura , Buckley Adam , Ashraf Tanveer , Barakat Maha T , Lessan Nader

Camel milk provides a modest portion of the overall global milk share but is an important source of protein in arid regions. Perceived health benefits include anti-diabetic properties attributed to its unique composition. We hypothesise that exogenous insulin present in camel milk mediates a hypoglycaemic effect. In a randomised, double blind crossover study, eleven normoglycaemic individuals were allocated to receive a 300 kcal pre-load of camel milk or cow milk ten minutes p...

ea0070ep143 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Lipoatrophy in a patient with type 1 diabetes: Genetic or immunological?

Ashraf Tanveer , Awad Nisreen , Suliman Sara , Helal Radwa , Naqvi Safdar , Lessan Nader

We report the case of a 28-year-old Emirati lady with type 1 diabetes (weight 51 kg, BMI 20.82 kg/m2) diagnosed at 3 years of age who presented to our centre with problems at her insulin injection sites. She had poor glycaemic control and her diabetes was complicated by retinopathy; other past medical history included vitamin D deficiency. All her seven siblings had diabetes and were on insulin; both parents had type 2 diabetes.In 2017, she wa...

ea0099ep666 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Monogenic obesity prevalence and response to bariatric surgery in a cohort of Emirati patients

Ashraf Tanveer , AlKaf Budour , Radha Saradalekshmi , Fojas Esphie , Baqer Amal , Khaled Rayan , Suliman Sara , Allum Matthew , Lessan Nader

Introduction: We have previously shown good short-term but variable long-term weight loss outcomes of bariatric surgery (BS) in a cohort of obese patients with MC4R deficiency. This study aims to elucidate the epidemiological landscape of Monogenic Obesity (MO) and quantify bariatric surgery’s effectiveness in weight reduction among Emirati patients with severe obesity. Methods: We selected a group of patients with extreme obesity (>50 kg/m...